Ranbaxy Laboratories launched the U.K.'s first generic version of AstraZeneca's ($AZN) stomach drug Nexium. The brand is AZ's third-biggest seller, but it accounts for only $97 million in sales annually in Britain. Report
Ranbaxy Laboratories launched the U.K.'s first generic version of AstraZeneca's ($AZN) stomach drug Nexium. The brand is AZ's third-biggest seller, but it accounts for only $97 million in sales annually in Britain. Report